Gary Visner

Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses.

Long-Term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2X7.

Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension.

Identification of dedifferentiation and redevelopment phases during postpneumonectomy lung growth.

Inhibition of the purinergic pathway prolongs mouse lung allograft survival.

The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling.

Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

Paracorporeal lung assist device in infants and toddlers: Coming of age?

Outcomes of mechanical support in a pediatric lung transplant center.

Transplant center volume and outcomes in lung transplantation for cystic fibrosis.

Impact of gastroesophageal reflux and delayed gastric emptying on pediatric lung transplant outcomes.

Epstein-Barr viral loads do not predict post-transplant lymphoproliferative disorder in pediatric lung transplant recipients: A multicenter prospective cohort study.

Risk and outcomes of pulmonary fungal infection after pediatric lung transplantation.

Lymphatic Vessels: The Next Frontier in Lung Transplant.

Posterior Tracheopexy for Severe Tracheomalacia Associated with Esophageal Atresia (EA): Primary Treatment at the Time of Initial EA Repair versus Secondary Treatment.

RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia.

Descending Aortopexy and Posterior Tracheopexy for Severe Tracheomalacia and Left Mainstem Bronchomalacia.

Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration.

P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes.

Mitochondrial transplantation prolongs cold ischemia time in murine heart transplantation.

Treatment of severe persistent asthma with IL-6 receptor blockade.

Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study.

Medical Deferred Action - Living on Borrowed Time.

Mitochondrial transplantation enhances murine lung viability and recovery after ischemia-reperfusion injury.

Current evaluation and management of plastic bronchitis in the pediatric population.

When to consider a posterolateral descending aortopexy in addition to a posterior tracheopexy for the surgical treatment of symptomatic tracheobronchomalacia.

Epidemiology and persistence of rhinovirus in pediatric lung transplantation.

Pediatric lung transplant: Correlation of pretransplant condition with post-transplant outcomes.

The impact of gastrointestinal dysmotility on the aerodigestive microbiome of pediatric lung transplant recipients.

Remote intervention engagement and outcomes in the Clinical Trials in Organ Transplantation in Children consortium multisite trial.

miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy.

N-myc-interactor mediates microbiome induced epithelial to mesenchymal transition and is associated with chronic lung allograft dysfunction.